Ogan Gurel
Vorsitzender bei Estracure, Inc.
Profil
Ogan Gurel is currently the Chairman of Estracure, Inc. He was previously the President & Chief Executive Officer of DuraVest, Inc. from 2005 to 2006.
Gurel received his undergraduate degree from Harvard University in 1986, his graduate degree from The Trustees of Columbia University in The City of New York in 1991, and his doctorate degree from The Trustees of Columbia University in The City of New York in 1996.
Aktive Positionen von Ogan Gurel
| Unternehmen | Position | Beginn |
|---|---|---|
Estracure, Inc.
 Estracure, Inc. Medical SpecialtiesHealth Technology Part of DuraVest, Inc., Estracure, Inc. designs and develops cardio therapeutics used by patients with heart conditions. The company is based in Montréal, Canada. Estracure was acquired by Cardio Management Systems, Inc., part of DuraVest, Inc. from January 18, 2005 on December 14, 2004 for $6.29 million. | Vorsitzender | - |
Ehemalige bekannte Positionen von Ogan Gurel
| Unternehmen | Position | Ende |
|---|---|---|
DuraVest, Inc.
 DuraVest, Inc. MiscellaneousMiscellaneous DuraVest, Inc. engages in the acquisition and development of medical technologies. The company was founded in 1980 and is headquartered in Chicago, IL. | Präsident | 13.09.2006 |
Ausbildung von Ogan Gurel
| Harvard University | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
DuraVest, Inc.
DuraVest, Inc. MiscellaneousMiscellaneous DuraVest, Inc. engages in the acquisition and development of medical technologies. The company was founded in 1980 and is headquartered in Chicago, IL. | Miscellaneous |
Estracure, Inc.
Estracure, Inc. Medical SpecialtiesHealth Technology Part of DuraVest, Inc., Estracure, Inc. designs and develops cardio therapeutics used by patients with heart conditions. The company is based in Montréal, Canada. Estracure was acquired by Cardio Management Systems, Inc., part of DuraVest, Inc. from January 18, 2005 on December 14, 2004 for $6.29 million. | Health Technology |
